FAK has been studied more in cell types of solid tissue origin than in leukocytes; for this reason, further research about FAK in the hematological/immunological context is required, and the aim of this review is to shed light on the current knowledge of FAK within the immune cell, with a particular focus on hematological malignancies. The gene discussed is PTK2; the disease is hematologic disorder.